Le Lézard
Classified in: Health, Business
Subjects: FNC, ACC

ElastiMed Secures Additional US$1 Million in Funding


MISGAV, Israel, September 25, 2017 /PRNewswire/ --

ElastiMed Ltd. ("ElastiMed"), announced that it recently raised US$1 million from a strategic investor, existing investors - The Trendlines Group (SGX: 42T) (OTCQX: TRNLY) and Pix Vine Capital - new private investors, and the Israeli Innovation Authority. This represents the Company's second round of funding, bringing total raises to US$2 million to date. Funds will be used to conduct a clinical study, regulatory filings, and to further expand the Company's current intellectual property.

ElastiMed has developed a wearable medical device improving circulation in the legs for the treatment of venous and lymphatic diseases. Based on proprietary technology and utilizing innovative smart materials, ElastiMed's device compresses and massages the legs when stimulated by an electric pulse. The smart sock provides patients with a comfortable, easy-to-wear, highly effective, and affordable treatment option to prevent symptoms such as swelling, blood clots, leg ulcers, and sports injuries.

Omer Zelka, Founder & CEO of ElastiMed, commented: "We are thrilled with the support and interest that our existing and new investors have demonstrated. It is indeed a vote of confidence in ElastiMed's future and potential."

Todd Dollinger, Chairman and CEO of Trendlines, added: "ElastiMed's huge market is clearly in need of better solutions for chronic edema and DVT. We are proud of ElastiMed's achievements so far and look forward to seeing them enter the marketplace."

Patrick De Silva, Chief Investment Partner of Pix Vine Capital, said : "We are excited to continue our support in the potential commercialization of a usable and effective wearable device, to help treat chronic edema and to prevent DVT."

About ElastiMed

ElastiMed is an Israeli medical device company that develops a wearable medical device to improve circulation in the legs for the treatment of venous and lymphatic diseases.

Chronic leg swelling (edema), which is caused by poor circulation, affects more than 7.4 million people in the United States alone[1]. Edema may result from old age, cancer treatments, poor diet or pregnancy. Blood clots, which are formed in the legs (DVT, deep vein thrombosis), affect over 790,000 people in the United States and EU[2]. Applying constant or changing external pressure on the legs has been proven to be a highly effective treatment to improve circulation and reduce swelling[3]. With a more than 60% non-compliance[4] rate for existing treatment options, ElastiMed's device is aimed at improving patient compliance with a comfortable, highly effective clinical treatment. ElastiMed addresses a potential worldwide market of US$3.3 billion.

[1] MNT 2017
(http://www.medicalnewstoday.com/articles/159111.php ), Lymphatic network 2017 (http://lymphaticnetwork.org/living-with-lymphedema/lymphedema-and-lymphatic-diseases-affect-millions-and-concern-us-all )

[2]Aspen 2015 (http://www.aspenpharma.eu/services/thrombosis-knowledge-center/venous-thromboembolic-events/ ), CDC 2015 (https://www.cdc.gov/ncbddd/dvt/data.html )

[3]NCBI 2015 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692571/)

[4]Phlebolymphology 2008 (https://www.phlebolymphology.org/compliance-with-compression-stockings-in-chronic-venous-disease/ )


Contact:
[email protected]
http://www.elastimed.com
+972-72-260-7051

SOURCE ElastiMed Ltd


These press releases may also interest you

at 02:00
C.K. McWhorter, chairman of the McWhorter Foundation, voices concerns over outdated perspectives in corporate leadership, exemplified by recent remarks from Nelson Peltz regarding Disney's film direction. After encountering instances of racism and...

at 02:00
OKX, a leading crypto exchange by trading volume and a leading Web3 technology company, has issued updates for March 29, 2024. OKX...

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

at 00:24
In the news release, Roborock Reports 2023 Full Year Financial Results, issued 28-Mar-2024 by Roborock over PR Newswire, we are advised by the company that in the first bullet point of "Growth across Product Categories", the USD amount should read...

28 mar 2024
Royal Bank of Canada ("RBC") today announced it has completed the acquisition of HSBC Bank Canada ("HSBC Canada"). "Today marks one of the most exciting times of our 155-year history and a pivotal milestone in our long-term growth story as we...

28 mar 2024
The opening ceremony of the Boao Forum for Asia (BFA) Annual Conference 2024 was held in Boao, south China's Hainan Province on Thursday, with China's top legislator Zhao Leji stressing China's economic potential, appealing to international investors...



News published on and distributed by: